معرفی
Laura Mezzanotte is an Associate Professor in the Department of Radiology & Nuclear Medicine at Erasmus MC, where she conducts cutting-edge research in molecular imaging, bioluminescence, and targeted cancer therapies. Her work bridges pharmacology, oncology, and nanotechnology to develop innovative diagnostic and therapeutic strategies.
Her research interests focus on bioluminescence imaging, luciferase-based reporter systems, nanoparticle drug delivery, and photodynamic therapy. She explores applications in glioblastoma, prostate cancer, and immunomodulation, particularly in the context of T cell exhaustion and immune checkpoint inhibition. Her work leverages molecular tools such as aptamers, NIR-dyes, and PSMA-targeted compounds for precision oncology.
The recent trend in her publications highlights a strong emphasis on in vivo imaging, combination therapies, and nanocarrier optimization. Her studies integrate preclinical validation with molecular design, aiming to translate imaging and therapeutic innovations into clinical applications. Topics span from antimicrobial implants to dual-color bioluminescence systems for immune monitoring.
Scientific Contributions:
- Developed novel bioluminescent reporter models for immunological studies.
- Engineered targeted nanoparticles for cancer visualization and treatment.
- Explored combination therapies involving photodynamic treatment and immunotherapy.
- Advanced understanding of material-implant interactions in antimicrobial contexts.
She has supervised multiple research projects, indicating active mentorship in training the next generation of scientists. Her collaborative network spans immunology, oncology, and materials science, reflecting interdisciplinary research. While no specific awards are listed, her consistent high-impact publications suggest recognition in her field. She leads research in a dynamic lab environment focused on translational molecular imaging and therapeutic development.